Long-Term Effects of Soliris Treatment: What Patients Should Know
Soliris, also known as eculizumab, is a medication used to treat a range of conditions, including paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and certain types of kidney transplant rejection. While Soliris has been shown to be effective in managing these conditions, there are concerns about its long-term effects.
Risk of Infection
One of the most significant long-term effects of Soliris treatment is the risk of infection [1]. Patients taking Soliris have an increased risk of developing certain infections, including meningococcal infections, which can be life-threatening. This is because Soliris inhibits the complement system, which is a key part of the immune system that helps fight infections.
Neurological Effects
There have been reports of neurological effects associated with long-term Soliris treatment, including headache, dizziness, and fatigue. In rare cases, patients have experienced more severe neurological effects, such as seizures, confusion, and even stroke [2]. The exact cause of these effects is not fully understood, but they may be related to the way Soliris affects the complement system.
Kidney Function
Soliris is primarily used to treat conditions that affect the kidneys, such as PNH and aHUS. While Soliris has been shown to be effective in managing these conditions, there is a risk that it could exacerbate kidney function over the long term [3]. Patients who take Soliris may need to be monitored closely to ensure that their kidney function is not deteriorating.
Other Long-Term Effects
In addition to the above effects, there have been reports of other long-term effects associated with Soliris treatment, including:
* Bleeding disorders: Soliris can increase the risk of bleeding disorders, including gastrointestinal bleeding and hemorrhage.
* Hypertension: Some patients have experienced hypertension while taking Soliris.
* Allergic reactions: Some patients have experienced allergic reactions to Soliris, including anaphylaxis.
What Do Patients Need to Know?
If you are taking Soliris, it is essential to work closely with your healthcare provider to monitor your condition and manage any potential side effects. Your healthcare provider will need to monitor your kidney function, blood pressure, and immune system regularly to ensure that you are not experiencing any adverse effects. It is also essential to take steps to prevent infections, such as getting vaccinated against meningococcus.
Alternatives to Soliris
There are alternative treatments available for conditions such as PNH and aHUS. Your healthcare provider will be able to discuss these alternatives with you and help you make an informed decision.
Sources:
[1] Alexion Pharmaceuticals, Inc. (2020). Soliris (eculizumab) prescribing information.
[2] European Medicines Agency (2019). Eculizumab: EPAR – Product Information.
[3] National Kidney Foundation (2020). Paroxysmal Nocturnal Hemoglobinuria (PNH): What You Need to Know.
Sources Used:
1. DrugPatentWatch.com
2. European Medicines Agency (EMA)
https://www.ema.europa.eu/en/
3. National Kidney Foundation (NKF)
https://www.kidney.org/
Note: This page is not intended to provide complete and exhaustive information on the subject. Please consult licensed medical healthcare professionals in your jurisdiction to gather more information. Always refer to the latest version of the prescribing information for Soliris (eculizumab).